Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Helius Medical Technologies Inc Class A

HSDT
Current price
4.16 USD -0.073 USD (-1.73%)
Last closed 4.31 USD
ISIN US42328V6039
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 887 043 USD
Yield for 12 month -81.74 %
1Y
3Y
5Y
10Y
15Y
HSDT
21.11.2021 - 28.11.2021

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania. Address: 642 Newtown Yardley Road, Newtown, PA, United States, 18940

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.00 USD

P/E ratio

Dividend Yield

Current Year

+520 000 USD

Last Year

+644 000 USD

Current Quarter

+49 000 USD

Last Quarter

+152 000 USD

Current Year

-62 000 USD

Last Year

+61 000 USD

Current Quarter

-72 000 USD

Last Quarter

-2 000 USD

Key Figures HSDT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -14 406 000 USD
Operating Margin TTM -8 185.71 %
Price to Earnings
Return On Assets TTM -195.57 %
PEG Ratio
Return On Equity TTM -800.00 %
Wall Street Target Price 4.00 USD
Revenue TTM 434 000 USD
Book Value 3.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -63.70 %
Dividend Yield
Gross Profit TTM -146 000 USD
Earnings per share -64.95 USD
Diluted Eps TTM -64.95 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics HSDT

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History HSDT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio TTM
Last Split Date 02.05.2025

Stock Valuation HSDT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 52.01
Price Sales TTM 64.80
Enterprise Value EBITDA -0.0076
Price Book MRQ 26.56

Financials HSDT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HSDT

For 52 weeks

3.32 USD 26.35 USD
50 Day MA 5.67 USD
Shares Short Prior Month 16 608
200 Day MA 8.76 USD
Short Ratio 0.25
Shares Short 17 326
Short Percent 0.020 %